GeneBio Systems
Recombinant Human SRC/Proto-oncogene c-Src Protein (His Tag)
Recombinant Human SRC/Proto-oncogene c-Src Protein (His Tag)
SKU:PDEH100688
Couldn't load pickup availability
Size:100μg
Storage:Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Shipping:This product is provided as lyophilized powder which is shipped with ice packs.
Exp date:12 months
Category ID_II:Recombinant Proteins
Category ID_III:Others
Abbreviation:SRC;Proto-oncogene c-Src
Target Synonym:Proto-oncogene c-Src;Proto-oncogene tyrosine-protein kinase Src;SRC1;p60-Src;pp60c-src
Research Areas:Signal Transduction,Epigenetics and Nuclear Signaling,Cancer
Conjugation:
Target Species:Human
Expression Host:E.coli
Application:
Fusion tag:N-His
UNIProt ID:P12931
Accession:P12931-1
Background:Proto-oncogene tyrosine-protein kinase SRC is a hydrophobic protein belonging to the SRC family kinase including nine members that is a family of non-receptor tyrosine kinases. SRC protein may exist in different forms: C-SRC and V-SRC. C-SRC is only activated under certain circumstances where it is required such as growth factor signaling, while V-SRC is constitutively active as opposed to normal SRC (C-SRC). Thus, V-SRC is an instructive example of an oncogene protein kinase whereas C-SRC is a proto-oncogene protein kinase. Inhibition of SRC with NR2A tyrosine phosphorylation mediated by PSD-95 may contribute to the lithium-induced downregulation of NMDA receptor function and provide neuroprotection against excitotoxicity.
Concentration:
Activity:Not validated for activity
Sequence:Gly2-Gly287
Purity: > 90% as determined by reducing SDS-PAGE.
Formulation:Lyophilized from sterile PBS, pH 7.4.
Normally 5%-8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Reconstitution:It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis.
Endotoxin:< 10 EU/mg of the protein as determined by the LAL method.
Calculated MW:31.2 kDa
ObservedMW:32.4 kDa
